Compositions for the treatment and diagnosis of breast cancer and methods for their use
Abstract
[Subject] Offer the compound and method for the medical treatment of cancer like a breast cancer, and diagnosis. [Solution means] This Ganke 合物 may contain the polynucleotide which carries out the code of one or more breast tumor protein, its immunogenicity portion, or such portions. Or a medical treatment composite may contain a specific T-lymph cell in the antigen presenting cells which reveal breast tumor protein, or the cell which reveals such protein. Such a composite may be used for, for example, accumulating in prevention and disposal of a disease like a breast cancer. The diagnostic method based on the process of detecting mRNA which carries out the code of breast tumor protein or such protein is also offered. [Selection figure] Nothing
Term
Term ended
Expired 15 February 2020, 6.6 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
82 members in 21 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 28548099 | United States of America | A | |
| 33933899 | United States of America | A | |
| 38968199 | United States of America | A | |
| 43382699 | United States of America | A | |
| 0005308 | United States of America | W |
Members82
| Document | Office | Kind | |
|---|---|---|---|
| CA2365221A1 | Canada | A1 | |
| WO0060076A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU4005200A | Australia | A | |
| NO20014769D0 | Norway | D0 | |
| CA2406213A1 | Canada | A1 | |
| WO0179286A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU5536901A | Australia | A | |
| NO20014769L | Norway | L | |
| WO0060076A3 | World Intellectual Property Organization (WIPO) | A3 | |
| BR0009537A | Brazil | A | |
| KR20020007348A | Republic of Korea | A | |
| EP1183348A2 | European Patent Office (EPO) | A2 | |
| MXPA01009956A | Mexico | A | |
| US6387697B1 | United States of America | B1 | |
| US2002064872A1 | United States of America | A1 | |
| CN1354791A | China | A | |
| HU0200763A2 | Hungary | A2 | |
| HUP0200763A2 | Hungary | A2 | |
| IL145620A0 | Israel | A0 | |
| US2002085998A1 | United States of America | A1 | |
| US2002102602A1 | United States of America | A1 | |
| TR2001003560T2 | Türkiye | T2 | |
| TR200103560T2 | Türkiye | T2 | |
| NO20024972D0 | Norway | D0 | |
| US2002150581A1 | United States of America | A1 | |
| WO02083956A1 | World Intellectual Property Organization (WIPO) | A1 | |
| JP2002540789A | Japan | A | |
| NO20024972L | Norway | L | |
| US2003023036A1 | United States of America | A1 | |
| WO0179286A3 | World Intellectual Property Organization (WIPO) | A3 | |
| HK1047134A | Hong Kong, China | A | |
| HK1047134A1 | Hong Kong, China | A1 | |
| US6518237B1 | United States of America | B1 | |
| US6528054B1 | United States of America | B1 | |
| EP1299417A2 | European Patent Office (EPO) | A2 | |
| MXPA02010244A | Mexico | A | |
| ZA200108065B | South Africa | B | |
| IL152221A0 | Israel | A0 | |
| US6573368B2 | United States of America | B2 | |
| US2003104366A1 | United States of America | A1 | |
| US6579973B1 | United States of America | B1 | |
| US6586572B2 | United States of America | B2 | |
| US6590076B1 | United States of America | B1 | |
| US2003166022A1 | United States of America | A1 | |
| PL353246A1 | Poland | A1 | |
| US2003229020A1 | United States of America | A1 | |
| US6680197B2 | United States of America | B2 | |
| BR0110091A | Brazil | A | |
| RU2002130715A | Russian Federation | A | |
| ZA200208365B | South Africa | B | |
| HU0301740A2 | Hungary | A2 | |
| HUP0301740A2 | Hungary | A2 | |
| US6756477B1 | United States of America | B1 | |
| JP2004520802A | Japan | A | |
| NZ514351A | New Zealand | A | |
| NZ521865A | New Zealand | A | |
| PL365244A1 | Poland | A1 | |
| US6844325B2 | United States of America | B2 | |
| CN1646563A | China | A | |
| US6958361B2 | United States of America | B2 | |
| US6969518B2 | United States of America | B2 | |
| US2006069054A1 | United States of America | A1 | |
| AU784688B2 | Australia | B2 | |
| US2008200386A1 | United States of America | A1 | |
| US2008206250A1 | United States of America | A1 | |
| US2008207486A1 | United States of America | A1 | |
| US2008207511A1 | United States of America | A1 | |
| US2008207547A1 | United States of America | A1 | |
| US2008207548A1 | United States of America | A1 | |
| US2008227739A1 | United States of America | A1 | |
| RU2344831C2 | Russian Federation | C2 | |
| US7598226B2 | United States of America | B2 | |
| JP2010239970A | Japan | A | |
| US7855271B2 | United States of America | B2 | |
| US2011104211A1 | United States of America | A1 | |
| EP1183348B1 | European Patent Office (EPO) | B1 | |
| AT514780TThis record | Austria | T | |
| ATE514780T1 | Austria | T1 | |
| JP4806124B2 | Japan | B2 | |
| ES2368899T3 | Spain | T3 | |
| US8182823B2 | United States of America | B2 | |
| JP5053497B2 | Japan | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 919352
Titles2
- German
- ZUSAMMENSETZUNGEN FÜR DIE THERAPIE UND DIAGNOSE VON BRUSTKREBS UND VERWENDUNG DAVON
- English
- COMPOSITIONS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER AND USE THEREOF
Classification
- CPC, 9
- C07K14/47
- A61K35/12
- A61K38/00
- A61K39/00
- A61P35/00
- C07K2319/00
- C12N9/00
- C12Q1/6886
- C12Q2600/118
- IPC, 31
- A61K
- A61K35 12
- A61K35 14
- A61K35 76
- A61K38 00
- A61K38 17
- A61K39 00
- A61K39 39
- A61K39 395
- A61K48 00
- A61P35 00
- C07K
- C07K14 47
- C07K14 82
- C07K16 32
- C07K19 00
- C12N
- C12N1 15
- C12N1 19
- C12N1 21
- C12N15 09
- C12N15 12
- C12N15 52
- C12N5 10
- C12N9 00
- C12Q
- C12Q1 68
- G01N
- G01N33 53
- G01N33 566
- G01N33 577